Drug General Information
Drug ID
D0A5AT
Former ID
DNC009300
Drug Name
KNI-10079
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529771]
Structure
Download
2D MOL

3D MOL

Formula
C34H39N3O6S
Canonical SMILES
CC1=CC=CC=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)<br />NC4C(CC5=CC=CC=C45)O)(C)C)O
InChI
1S/C34H39N3O6S/c1-21-11-7-10-16-27(21)43-19-28(39)35-25(17-22-12-5-4-6-13-22)30(40)33(42)37-20-44-34(2,3)31(37)32(41)36-29-24-15-9-8-14-23(24)18-26(29)38/h4-16,25-26,29-31,38,40H,17-20H2,1-3H3,(H,35,39)(H,36,41)/t25-,26+,29-,30-,31+/m0/s1
InChIKey
LXIUKNRDJTWBGH-XPLSERNMSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [529771]
References
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.